The vitamin D receptor is involved in the regulation of human breast cancer cell growth via a ligand-independent function in cytoplasm

Trupti Trivedi, Yu Zheng, Pierrick G.J. Fournier, Sreemala Murthy, Sutha John, Suzanne Schillo, Colin R. Dunstan, Khalid Mohammad, Hong Zhou, Markus J. Seibel, Theresa Guise

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

Vitamin D has pleiotropic effects on multiple tissues, including malignant tumors. Vitamin D inhibits breast cancer growth through activation of the vitamin D receptor (VDR) and via classical nuclear signaling pathways. Here, we demonstrate that the VDR can also function in the absence of its ligand to control behaviour of human breast cancer cells both outside and within the bone microenvironment. Stable shRNA expression was used to knock down VDR expression in MCF-7 cells, generating two VDR knockdown clonal lines. In ligand-free culture, knockdown of VDR in MCF-7 cells significantly reduced proliferation and increased apoptosis, suggesting that the VDR plays a ligand-independent role in cancer cell growth. Implantation of these VDR knockdown cells into the mammary fat pad of nude mice resulted in reduced tumor growth in vivo compared with controls. In the intra-tibial xenograft model, VDR knockdown greatly reduced the ability of the cells to form tumors in the bone microenvironment. The in vitro growth of VDR knockdown cells was rescued by the expression of a mutant form of VDR which is unable to translocate to the nucleus and hence accumulates in the cytoplasm. Thus, our data indicate that in the absence of ligand, the VDR promotes breast cancer growth both in vitro and in vivo and that cytoplasmic accumulation of VDR is sufficient to produce this effect in vitro. This new mechanism of VDR action in breast cancer cells contrasts the known anti-proliferative nuclear actions of the VDR-vitamin D ligand complex.

Original languageEnglish (US)
Pages (from-to)26687-26701
Number of pages15
JournalOncotarget
Volume8
Issue number16
DOIs
StatePublished - 2017

Fingerprint

Calcitriol Receptors
Cytoplasm
Breast Neoplasms
Ligands
Growth
Vitamin D
MCF-7 Cells
Neoplasms
Bone and Bones
Behavior Control
Aptitude
Heterografts
Nude Mice
Small Interfering RNA
Adipose Tissue

Keywords

  • Bone metastasis
  • Breast cancer
  • Ligand independent
  • Vitamin D
  • Vitamin D receptor

ASJC Scopus subject areas

  • Oncology

Cite this

The vitamin D receptor is involved in the regulation of human breast cancer cell growth via a ligand-independent function in cytoplasm. / Trivedi, Trupti; Zheng, Yu; Fournier, Pierrick G.J.; Murthy, Sreemala; John, Sutha; Schillo, Suzanne; Dunstan, Colin R.; Mohammad, Khalid; Zhou, Hong; Seibel, Markus J.; Guise, Theresa.

In: Oncotarget, Vol. 8, No. 16, 2017, p. 26687-26701.

Research output: Contribution to journalArticle

Trivedi, T, Zheng, Y, Fournier, PGJ, Murthy, S, John, S, Schillo, S, Dunstan, CR, Mohammad, K, Zhou, H, Seibel, MJ & Guise, T 2017, 'The vitamin D receptor is involved in the regulation of human breast cancer cell growth via a ligand-independent function in cytoplasm', Oncotarget, vol. 8, no. 16, pp. 26687-26701. https://doi.org/10.18632/oncotarget.15803
Trivedi, Trupti ; Zheng, Yu ; Fournier, Pierrick G.J. ; Murthy, Sreemala ; John, Sutha ; Schillo, Suzanne ; Dunstan, Colin R. ; Mohammad, Khalid ; Zhou, Hong ; Seibel, Markus J. ; Guise, Theresa. / The vitamin D receptor is involved in the regulation of human breast cancer cell growth via a ligand-independent function in cytoplasm. In: Oncotarget. 2017 ; Vol. 8, No. 16. pp. 26687-26701.
@article{82845bb787524cf2b38cf6bb7434eda2,
title = "The vitamin D receptor is involved in the regulation of human breast cancer cell growth via a ligand-independent function in cytoplasm",
abstract = "Vitamin D has pleiotropic effects on multiple tissues, including malignant tumors. Vitamin D inhibits breast cancer growth through activation of the vitamin D receptor (VDR) and via classical nuclear signaling pathways. Here, we demonstrate that the VDR can also function in the absence of its ligand to control behaviour of human breast cancer cells both outside and within the bone microenvironment. Stable shRNA expression was used to knock down VDR expression in MCF-7 cells, generating two VDR knockdown clonal lines. In ligand-free culture, knockdown of VDR in MCF-7 cells significantly reduced proliferation and increased apoptosis, suggesting that the VDR plays a ligand-independent role in cancer cell growth. Implantation of these VDR knockdown cells into the mammary fat pad of nude mice resulted in reduced tumor growth in vivo compared with controls. In the intra-tibial xenograft model, VDR knockdown greatly reduced the ability of the cells to form tumors in the bone microenvironment. The in vitro growth of VDR knockdown cells was rescued by the expression of a mutant form of VDR which is unable to translocate to the nucleus and hence accumulates in the cytoplasm. Thus, our data indicate that in the absence of ligand, the VDR promotes breast cancer growth both in vitro and in vivo and that cytoplasmic accumulation of VDR is sufficient to produce this effect in vitro. This new mechanism of VDR action in breast cancer cells contrasts the known anti-proliferative nuclear actions of the VDR-vitamin D ligand complex.",
keywords = "Bone metastasis, Breast cancer, Ligand independent, Vitamin D, Vitamin D receptor",
author = "Trupti Trivedi and Yu Zheng and Fournier, {Pierrick G.J.} and Sreemala Murthy and Sutha John and Suzanne Schillo and Dunstan, {Colin R.} and Khalid Mohammad and Hong Zhou and Seibel, {Markus J.} and Theresa Guise",
year = "2017",
doi = "10.18632/oncotarget.15803",
language = "English (US)",
volume = "8",
pages = "26687--26701",
journal = "Oncotarget",
issn = "1949-2553",
publisher = "Impact Journals",
number = "16",

}

TY - JOUR

T1 - The vitamin D receptor is involved in the regulation of human breast cancer cell growth via a ligand-independent function in cytoplasm

AU - Trivedi, Trupti

AU - Zheng, Yu

AU - Fournier, Pierrick G.J.

AU - Murthy, Sreemala

AU - John, Sutha

AU - Schillo, Suzanne

AU - Dunstan, Colin R.

AU - Mohammad, Khalid

AU - Zhou, Hong

AU - Seibel, Markus J.

AU - Guise, Theresa

PY - 2017

Y1 - 2017

N2 - Vitamin D has pleiotropic effects on multiple tissues, including malignant tumors. Vitamin D inhibits breast cancer growth through activation of the vitamin D receptor (VDR) and via classical nuclear signaling pathways. Here, we demonstrate that the VDR can also function in the absence of its ligand to control behaviour of human breast cancer cells both outside and within the bone microenvironment. Stable shRNA expression was used to knock down VDR expression in MCF-7 cells, generating two VDR knockdown clonal lines. In ligand-free culture, knockdown of VDR in MCF-7 cells significantly reduced proliferation and increased apoptosis, suggesting that the VDR plays a ligand-independent role in cancer cell growth. Implantation of these VDR knockdown cells into the mammary fat pad of nude mice resulted in reduced tumor growth in vivo compared with controls. In the intra-tibial xenograft model, VDR knockdown greatly reduced the ability of the cells to form tumors in the bone microenvironment. The in vitro growth of VDR knockdown cells was rescued by the expression of a mutant form of VDR which is unable to translocate to the nucleus and hence accumulates in the cytoplasm. Thus, our data indicate that in the absence of ligand, the VDR promotes breast cancer growth both in vitro and in vivo and that cytoplasmic accumulation of VDR is sufficient to produce this effect in vitro. This new mechanism of VDR action in breast cancer cells contrasts the known anti-proliferative nuclear actions of the VDR-vitamin D ligand complex.

AB - Vitamin D has pleiotropic effects on multiple tissues, including malignant tumors. Vitamin D inhibits breast cancer growth through activation of the vitamin D receptor (VDR) and via classical nuclear signaling pathways. Here, we demonstrate that the VDR can also function in the absence of its ligand to control behaviour of human breast cancer cells both outside and within the bone microenvironment. Stable shRNA expression was used to knock down VDR expression in MCF-7 cells, generating two VDR knockdown clonal lines. In ligand-free culture, knockdown of VDR in MCF-7 cells significantly reduced proliferation and increased apoptosis, suggesting that the VDR plays a ligand-independent role in cancer cell growth. Implantation of these VDR knockdown cells into the mammary fat pad of nude mice resulted in reduced tumor growth in vivo compared with controls. In the intra-tibial xenograft model, VDR knockdown greatly reduced the ability of the cells to form tumors in the bone microenvironment. The in vitro growth of VDR knockdown cells was rescued by the expression of a mutant form of VDR which is unable to translocate to the nucleus and hence accumulates in the cytoplasm. Thus, our data indicate that in the absence of ligand, the VDR promotes breast cancer growth both in vitro and in vivo and that cytoplasmic accumulation of VDR is sufficient to produce this effect in vitro. This new mechanism of VDR action in breast cancer cells contrasts the known anti-proliferative nuclear actions of the VDR-vitamin D ligand complex.

KW - Bone metastasis

KW - Breast cancer

KW - Ligand independent

KW - Vitamin D

KW - Vitamin D receptor

UR - http://www.scopus.com/inward/record.url?scp=85017509346&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85017509346&partnerID=8YFLogxK

U2 - 10.18632/oncotarget.15803

DO - 10.18632/oncotarget.15803

M3 - Article

VL - 8

SP - 26687

EP - 26701

JO - Oncotarget

JF - Oncotarget

SN - 1949-2553

IS - 16

ER -